Abstract
Objective: Among patients with cutaneous melanoma of the head and neck (CMHN) and ≥1 positive sentinel lymph node (SLN): 1) Determine if completion regional lymphadenectomy (RL) is associated with improved survival.2) Determine if survival differs between patients with 1 and >1 positive SLN.
Method: Using the Surveillance Epidemiology and End Results (SEER) database, years 1998 to 2007, we identified 5,399 patients with primary CHNM who underwent excisional surgery and examination of ≥1 lymph node with follow-up >12 months. Clinicopathologic and outcomes data were examined using chi-square tests.
Results: In preliminary analysis, 495 patients had 1 positive node and 387 had >1 positive node. Disease-specific survival (DSS) was statistically different between these 2 groups (64% and 47%), respectively, chi-square p1 node were involved (P = .112 and .891 respectively).
Conclusion: In this simple preliminary analysis, CHNM patients with >1 positive lymph node had poorer survival compared with patients with a single positive lymph node. Among patients with SLN-positive CHNM, regional lymphadenectomy did not improve survival compared with patients who underwent SLNB alone. Formal survival analyses results will be presented.
Get full access to this article
View all access options for this article.